BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv6.6.1//EN
X-ORIGINAL-URL:https://vanguard-project.eu/
X-WR-CALNAME:VANGUARD
X-WR-CALDESC:New Generation Cell Therapy: Bioartificial Pancreas to Cure Type 1 Diabetes
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-2596a54cdbb555cfd09cd5d991da0f55@vanguard-project.eu
DTSTART:20241116T080000Z
DTEND:20241116T153000Z
DTSTAMP:20241029T091000Z
CREATED:20241029
LAST-MODIFIED:20241029
PRIORITY:5
SEQUENCE:9
TRANSP:OPAQUE
SUMMARY:46th Update Internal Medicine
DESCRIPTION:Date: 16 November 2024, 09:00–16:30\nLocation: Hybrid event – participate online or in person (Small Lecture Hall, LMU Klinikum Innenstadt, Ziemssenstr. 1, 80336 Munich)\nOnline Access: www.maaef.de/einloggen\nWe are pleased to announce that our VANGUARD project partner from Ludwig Maximilian University of Munich, Prof. Dr. Jochen Seißler, will present at this year’s 46th Update in Internal Medicine. His session, scheduled for 14:45, will focus on “Type 1 Diabetes Mellitus: Modern Treatment Strategies and Advances in Cell Therapy.” The presentation will be held in German and is open to all interested attendees, with a primary focus on general practitioners and specialists in internal medicine and diabetology.\nThis annual event serves as an informative platform for professionals engaged in conservative medicine, covering topics tailored to daily practice with a practical focus. The agenda is crafted based on feedback from previous participants to address the most relevant and requested topics in internal medicine.\nFor the full agenda and further event details, please visit https://maaef.de/veranstaltung/46-update-innere-medizin.\n
URL:https://vanguard-project.eu/events/46th-update-internal-medicine-munich-16-11-2024/
ATTACH;FMTTYPE=image/jpeg:https://vanguard-project.eu/wp-content/uploads/sites/23/2024/10/46-update-internal-medicine.jpg
END:VEVENT
END:VCALENDAR